why choose us

First received: January 17, 2023

Clinical Trial: A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Safety, Tolerability and Pharmacokinetic Study of Tirzepatide for the Treatment of Pediatric Participants (6 Years to 11 Years) With Obesity

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of tirzepatide (LY3298176) in pediatric participants with obesity.The blood tests will be performed to investigate how the body processes the study drug in these participants.For each participant, the study will last about approximately 13 weeks excluding the screening period.

Read more